| The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD) DM Tanase, EM Gosav, CF Costea, M Ciocoiu, CM Lacatusu, ... Journal of diabetes research 2020 (1), 3920196, 2020 | 351 | 2020 |
| Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker? DM Tanase, EM Gosav, S Radu, A Ouatu, C Rezus, M Ciocoiu, CF Costea, ... International journal of hypertension 2019 (1), 3159283, 2019 | 146 | 2019 |
| Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM) DM Tanase, EM Gosav, E Neculae, CF Costea, M Ciocoiu, LL Hurjui, ... Nutrients 12 (12), 3719, 2020 | 134 | 2020 |
| The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity DM Tanase, EM Gosav, S Radu, CF Costea, M Ciocoiu, A Carauleanu, ... International journal of molecular sciences 20 (20), 5238, 2019 | 132 | 2019 |
| Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives DM Tanase, EM Gosav, MI Anton, M Floria, PN Seritean Isac, LL Hurjui, ... Biomolecules 12 (9), 1227, 2022 | 64 | 2022 |
| Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): mechanisms and emerging therapeutic options DM Tanase, EM Gosav, E Neculae, CF Costea, M Ciocoiu, LL Hurjui, ... International Journal of Molecular Sciences 21 (16), 5927, 2020 | 43 | 2020 |
| Left atrial structural remodelling in non-valvular atrial fibrillation: what have we learnt from CMR? M Floria, S Radu, EM Gosav, D Cozma, O Mitu, A Ouatu, DM Tanase, ... Diagnostics 10 (3), 137, 2020 | 26 | 2020 |
| Seritean Isac PN, Hurjui LL, et al DM Tanase, EM Gosav, MI Anton, M Floria Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD …, 2022 | 18 | 2022 |
| Involvement of ceramides in non-alcoholic fatty liver disease (Nafld) atherosclerosis (ats) development: Mechanisms and therapeutic targets DM Tanase, EM Gosav, D Petrov, AE Jucan, CM Lacatusu, M Floria, ... Diagnostics 11 (11), 2053, 2021 | 16 | 2021 |
| Current knowledge of MicroRNAs (miRNAs) in acute coronary syndrome (ACS): ST-elevation myocardial infarction (STEMI) DM Tanase, EM Gosav, A Ouatu, MC Badescu, N Dima, ... Life 11 (10), 1057, 2021 | 16 | 2021 |
| Portrayal of NLRP3 inflammasome in atherosclerosis: current knowledge and therapeutic targets DM Tanase, E Valasciuc, EM Gosav, A Ouatu, ON Buliga-Finis, M Floria, ... International Journal of Molecular Sciences 24 (9), 8162, 2023 | 15 | 2023 |
| Cardiac optogenetics in atrial fibrillation: current challenges and future opportunities M Floria, S Radu, EM Gosav, AC Moraru, T Serban, A Carauleanu, ... BioMed Research International 2020 (1), 8814092, 2020 | 15 | 2020 |
| MicroRNAs (miRNAs) in cardiovascular complications of rheumatoid arthritis (RA): what is new? DM Tanase, EM Gosav, D Petrov, DS Teodorescu, ON Buliga-Finis, ... International Journal of Molecular Sciences 23 (9), 5254, 2022 | 13 | 2022 |
| Seritean Isac DM Tanase, EM Gosav, MI Anton, M Floria PN, Hurjui, LL, Tarniceriu, CC, Costea, CF, Ciocoiu, M., Rezus, C, 2022 | 11 | 2022 |
| Contribution of oxidative stress (OS) in calcific aortic valve disease (CAVD): From pathophysiology to therapeutic targets DM Tanase, E Valasciuc, EM Gosav, M Floria, CF Costea, N Dima, ... Cells 11 (17), 2663, 2022 | 10 | 2022 |
| Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease? ON Buliga-Finis, A Ouatu, DM Tanase, EM Gosav, PN Seritean Isac, ... Life 13 (6), 1311, 2023 | 7 | 2023 |
| The oral microbiota in valvular heart disease: current knowledge and future directions E Neculae, EM Gosav, E Valasciuc, N Dima, M Floria, DM Tanase Life 13 (1), 182, 2023 | 4 | 2023 |
| Depiction of branched-chain amino acids (BCAAs) in diabetes with a focus on diabetic microvascular complications DM Tanase, EM Gosav, T Botoc, M Floria, CC Tarniceriu, MA Maranduca, ... Journal of Clinical Medicine 12 (18), 6053, 2023 | 3 | 2023 |
| Implications of microbiota in the pathogenesis of diabetes mellitus and cardiovascular disease DM Tanase, AM Leustean, EM Gosav Gut Microbiota in Neurologic and Visceral Diseases, 159-184, 2021 | | 2021 |
